Table 4.
Seroprevalence of blood-borne diseases among persons screened during the study period.
| TTI | Donor group | Positive (%) | Negative (%) | Total N (%) | Chi square | p value | Relative risk |
|---|---|---|---|---|---|---|---|
| VNRD | 1 (0.37) | 268 (99.63) | 269 (100.0) | 1 | |||
| HIV | FRD | 87 (0.95) | 9037 (99.05) | 9124 (100.0) | 4.952 | 0.084 | 2.56 |
| PAID | 13 (0.49) | 2625 (99.51) | 2638 (100.0) | 1.33 | |||
| Total | 101 (0.82) | 11930 (99.18) | 12031 (100.0) | ||||
| VNRD | 4 (1.50) | 263 (98.50) | 267 (100.0) | 1 | |||
| HBV | FRD | 230 (2.52) | 8894 (97.48) | 9124 (100.0) | 14.940 | 0.001 | 1.68 |
| PAID | 33 (1.25) | 2602 (98.75) | 2635 (100.0) | 0.84 | |||
| Total | 267 (2.22) | 11759 (97.78) | 12026 (100.0) | ||||
| VNRD | 8 (3.0) | 259 (97.0) | 267 (100.0) | 1 | |||
| HCV | FRD | 199 (2.18) | 8925 (97.82) | 9124 (100.0) | 9.9392 | 0.009 | 0.73 |
| PAID | 33 (1.26) | 2595 (98.74) | 2628 (100.0) | 0.42 | |||
| Total | 240 (2.00) | 11779 (98.0) | 12019 (100.0) | ||||
| VNRD | 5 (1.87) | 262 (98.13) | 267 (100.0) | 1 | |||
| Syphilis | FRD | 203 (2.22) | 8921 (97.78) | 9124 (100.0) | 19.473 | 0.00006 | 1.19 |
| PAID | 22 (0.84) | 2598 (99.16) | 2620 (100.0) | 0.45 | |||
| Total | 230 (1.91) | 11781 (98.09) | 12011 |